Clinical Trials Browser

Phase 4 × Carcinoma, Non-Small-Cell Lung × Pemetrexed × Clear all

NCT03656549 2024-12-17

IMPROVE-I

Phase 4 Completed

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT06357598 2024-04-10

PILOT

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03655821 2022-05-13

IMPROVE-II

Phase 4 Terminated

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT03655834 2022-05-10

IMPROVE-III

Phase 4 Completed

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT03607149 2021-05-24

PKAPIR

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT03460678 2020-03-05

Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.

Phase 4 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01442909 2011-09-29

Pemetrexed Followed by Docetaxel or in Reverse Sequence

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00380718 2010-11-16

Chemotherapy for Patients With Non-Small Cell Lung Cancer

Phase 4 Completed

33 enrolled 26 charts

Carcinoma, Non-Small-Cell Lung